✦ LIBER ✦

Clinical experience with ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, in ischemic heart disease

✍ Scribed by Andrew A. Wolff; Sandra L. Skettino; Whedy Wang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranolazine, partial fatty acid oxidation

✍ Margaret P. Chandler; William C. Stanley; Hideaki Morita; George Suzuki; Omar Na 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Ranolazine, a partial fatty acid oxidati

✍ M.P. Chandler; W.C. Stanley; H. Morita; G. Suzuki; O. Nass; B. Blackburn; A. Wol 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 148 KB

A Randomized Clinical Trial of Trimetazi

✍ Gabriele Fragasso; Altin Palloshi; Patrizia Puccetti; Carmen Silipigni; Alessand 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 154 KB